HSP90AB1 and lung carcinoma: In addition, increased level of Hsp90-beta was observed in serum of the lung cancer patients (1.41 ± 0.48 ng/mL) compared with in serum of the control individuals (0.83 ± 0.37 ng/mL) (P < 0.001) (Fig. 1b).